US M&A and equity raisings

3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

Deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

4 deals · US$431mdisclosed · Life Sciences · Clear

Columns
US M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Dec 2025 Freenome ––PlacementCompleted240.0Diagnostics+2 Goodwin (issuer)Jefferies (lead manager)Leerink Partners (lead manager)White & Case (lead manager)
Apr 2026 Alamar Biosciences ––IPOListed191.3Life Sciences+1 Cooley (issuer)J.P. Morgan (lead manager)BofA Securities (lead manager)TD Securities (lead manager)Leerink Partners (lead manager)Stifel (lead manager)Latham & Watkins (lead manager)
May 2026 Conexeu Sciences ––Direct listingAnnounced–Life Sciences H.C. Wainwright & Co. (issuer)
Jul 2026 Codexis ––Follow-on offeringCompleted–Biotech+1 Piper Sandler (lead manager)

Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built